Home > Insider Trading > Filing (0001209191-19-048672)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1668243	Urogen Pharma Ltd.	URGN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1763581	Mark Schoenberg	C/O Urogen Pharma Ltd. 499 Park Avenue New York City NY 10022	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2019-09-04	1,041	$0.00	6,350	No	4	M	Direct
Ordinary Shares	Disposition	2019-09-04	343	$33.92	6,007	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Restricted Stock Units (RSUs)	Disposition	2019-09-04	1,041	$0.00	1,041	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,209			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
On December 7, 2017, the reporting person was granted restricted stock units ("RSUs") representing 12,500 ordinary shares. 1/3rd of the RSUs vested on December 4, 2018, with the balance vesting in equal quarterly installments thereafter over a period of two years.